BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 12860296)

  • 1. Differences in glycosylation of intracellular proteins between benign and malignant thyroid neoplasms.
    Krześlak A; Pomorski L; Gaj Z; Lipińska A
    Cancer Lett; 2003 Jun; 196(1):101-7. PubMed ID: 12860296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular glycoproteins binding galectin-1 in thyroid lesions.
    Gaj Z; Krzeslak A; Pomorski L; Lipinska A
    Tumori; 2009; 95(3):352-6. PubMed ID: 19688976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sialylation of intracellular proteins of thyroid lesions.
    Krzeslak A; Gaj Z; Pomorski L; Lipinska A
    Oncol Rep; 2007 May; 17(5):1237-42. PubMed ID: 17390071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helix pomatia agglutinin binding glycoproteins in thyroid tumors.
    Parameswaran R; Sadler G; Brooks S
    World J Surg; 2011 Oct; 35(10):2219-27. PubMed ID: 21845460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A method to differentiate between thyroglobulin derived from normal thyroid tissue and from thyroid carcinoma based on analysis of reactivity to lectins.
    Maruyama M; Kato R; Kobayashi S; Kasuga Y
    Arch Pathol Lab Med; 1998 Aug; 122(8):715-20. PubMed ID: 9701333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue binding pattern of plant lectins in benign and malignant lesions of thyroid.
    Vijayakumar T; Augustine J; Mathew L; Aleykutty MA; Nair MB; Remani P; Nair MK
    J Exp Pathol; 1992; 6(1-2):11-23. PubMed ID: 1625034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a new method for the diagnosis of alterations of Lens culinaris agglutinin binding of thyroglobulin molecules in thyroid carcinoma.
    Kanai T; Amakawa M; Kato R; Shimizu K; Nakamura K; Ito K; Hama Y; Fujimori M; Amano J
    Clin Chem Lab Med; 2009; 47(10):1285-90. PubMed ID: 19743952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of plant lectins on the survival and malignant behaviors of thyroid cancer cells.
    Kaptan E; Sancar-Bas S; Sancakli A; Bektas S; Bolkent S
    J Cell Biochem; 2018 Jul; 119(7):6274-6287. PubMed ID: 29663501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lectin-binding proteins in nuclear preparations from rat liver and malignant tumors.
    Burrus GR; Schmidt WN; Briggs JA; Hnilica LS; Briggs RC
    Cancer Res; 1988 Feb; 48(3):551-5. PubMed ID: 3335020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and confirmation of differentially expressed fucosylated glycoproteins in the serum of ovarian cancer patients using a lectin array and LC-MS/MS.
    Wu J; Xie X; Liu Y; He J; Benitez R; Buckanovich RJ; Lubman DM
    J Proteome Res; 2012 Sep; 11(9):4541-52. PubMed ID: 22827608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoplastic transformation of the thyroid gland is accompanied by changes in cellular sialylation.
    Babál P; Janega P; Cerná A; Kholová I; Brabencová E
    Acta Histochem; 2006; 108(2):133-40. PubMed ID: 16720036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
    Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
    Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrimination of thyroglobulin from thyroid carcinoma tissue and that from benign thyroid tissues with use of competitive assay between lectin and anti-thyroglobulin antibody.
    Shimizu K; Nakamura K; Kobatake S; Satomura S; Maruyama M; Tajiri J; Kato R
    Rinsho Byori; 2007 May; 55(5):428-33. PubMed ID: 17593687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
    Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
    Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lectin binding studies of parotid salivary glycoproteins in Sjögren's syndrome.
    Carpenter GH; Pankhurst CL; Proctor GB
    Electrophoresis; 1999 Jul; 20(10):2124-32. PubMed ID: 10451125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of lectin binding in benign and malignant thyroid nodules.
    Sasano H; Rojas M; Silverberg SG
    Arch Pathol Lab Med; 1989 Feb; 113(2):186-9. PubMed ID: 2916907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population heterogeneity in the surface expression of Ulex europaeus I-lectin (UEA I)-binding sites in cultured malignant and transformed cells.
    Virtanen I; Lehtonen E; Närvänen O; Leivo I; Lehto VP
    Exp Cell Res; 1985 Nov; 161(1):53-62. PubMed ID: 4054235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a lectin binding assay to differentiate between recombinant and endogenous proteins in pharmacokinetic studies of protein-biopharmaceuticals.
    Weber A; Minibeck E; Scheiflinger F; Turecek PL
    J Pharm Biomed Anal; 2015 Apr; 108():21-8. PubMed ID: 25703236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute-phase proteins investigation based on lectins affinity capture prior to 2-DE separation: application to serum from multiple sclerosis patients.
    Robotti A; Natale M; Albo AG; Lis K; Perga S; Marnetto F; Gilli F; Bertolotto A
    Electrophoresis; 2010 Sep; 31(17):2882-93. PubMed ID: 20715125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases.
    Puglisi F; Cesselli D; Damante G; Pellizzari L; Beltrami CA; Di Loreto C
    Anticancer Res; 2000; 20(1A):311-6. PubMed ID: 10769673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.